Top 2026 Therapeutics Early Stage Investors in United States, page 3

Investors 21 to 30 of 710, ranked by deals in Therapeutics. Back to the full list

Investor search results

712 investors found
🌍 United States📊 early stage🏷 Therapeutics
Chris O'Donnell
Chris O'Donnell
Board Observer at Kestrel Therapeutics
Mid stage5 in Therapeutics9 investments 📍 United States
5
in Therapeutics
Kou Qin, PhD
Kou Qin, PhD
Investor @ SIIC Capital | Biotech, AI
Mid stage5 in Therapeutics13 investments 📍 United States
5
in Therapeutics
Joseph Oberholtzer
Joseph Oberholtzer
Director of Strategic Finance at Vera Therapeutics
Mid stage5 in Therapeutics10 investments 📍 United States
5
in Therapeutics
Hannah Chang, M.D., Ph.D.
Hannah Chang, M.D., Ph.D.
Life sciences VC | Physician scientist | Builder
Early stage5 in Therapeutics11 investments 📍 United States
5
in Therapeutics
Chas Pulido
Chas Pulido
General Partner @ Alix Ventures | Creator @ BIOS | TechBio | Computational Health | Community Builder | LP | Angel | YC S18 | Forbes 30u30 | BI Rising Star VC
Early stage5 in Therapeutics22 investments 📍 United States
5
in Therapeutics
Charles Kunsch
Charles Kunsch
Biotech Investor and company builder, Board Member, Life science advisor
Early stage5 in Therapeutics14 investments 📍 United States
5
in Therapeutics
Kiersten Stead
Kiersten Stead
Managing Partner DCVC Bio: Scientist-investor in early staged deep tech life sciences
Early stage5 in Therapeutics23 investments 📍 United States
5
in Therapeutics
Krish W. Ramadurai
Krish W. Ramadurai
Partner at AIX Ventures | Author
Early stage5 in Therapeutics53 investments 📍 United States
5
in Therapeutics
Helen Liang, PhD
Helen Liang, PhD
Founder & Managing Partner of FoundersX Ventures. Board Director. Featured on WSJ and Business Insider. Invited Speaker at TechCrunch. Guest lecturer at Stanford. Nvidia VC Alliance Partner.
Early stage5 in Therapeutics76 investments 📍 United States
5
in Therapeutics
Craig Asher
Craig Asher
Managing Director at OMX Ventures
Early stage5 in Therapeutics37 investments 📍 United States
5
in Therapeutics

Contact all 710 Therapeutics early-stage investors

Gritt drafts a personalised AI email for each — written from your pitch; you approve each one, or let Gritt approve them for you, and it sends from your Gmail.

Start free — contact these investors
Joined by 10,600+ startups · no credit card required